Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction
1 other identifier
observational
492
1 country
1
Brief Summary
Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2019
CompletedFirst Submitted
Initial submission to the registry
July 2, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedJuly 8, 2019
July 1, 2019
7 months
July 2, 2019
July 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmission Risk Factors and Heart Failure with Preserved Ejection Fraction
Retrospective review to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.
August 1, 2017 though March 1, 2018
Study Arms (2)
readmission at 30 days
readmission at 90 days
Interventions
Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.
Eligibility Criteria
All
You may qualify if:
- History of Heart failure diagnosis admitted for treatment
- Ejection fraction \< 40% by echocardiogram
You may not qualify if:
- Ejection fraction \>40% by echocardiogram
- Chronic Kidney disease requiring dialysis
- Terminal illness
- New onset diagnosis of Heart Failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ascension Macomb-Oakland Hospital
Warren, Michigan, 48093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dustin Harmon, DO
Ascension Macomb-Oakland Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
July 2, 2019
First Posted
July 5, 2019
Study Start
August 1, 2017
Primary Completion
March 1, 2018
Study Completion
January 18, 2019
Last Updated
July 8, 2019
Record last verified: 2019-07